Do Been Hwang

Title: Do Been Hwang: Innovator in Antibody Complexes

Introduction

Do Been Hwang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody complexes. His innovative work has the potential to enhance biological assays and therapeutic applications.

Latest Patents

Hwang holds a patent for a complex in which an anti-cotinine antibody is bound to a conjugate of cotinine and a binding substance. This invention relates to a complex that can be utilized as an analysis tool in in vitro biological assay methods. The complex retains the specific reactivity and biological function of the binding material, while also possessing capabilities for inducing complement-mediated cell cytotoxicity (CDC) and antibody-dependent cell cytotoxicity (ADCC). Additionally, it offers a prolonged in vivo half-life, which are intrinsic characteristics of antibodies.

Career Highlights

Hwang is associated with the Snur & Db Foundation, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the application of scientific principles to real-world challenges.

Collaborations

Some of his coworkers include Junho Chung and Sunyoung Park, who contribute to the collaborative environment at the Snur & Db Foundation.

Conclusion

Do Been Hwang's contributions to the field of biotechnology through his patented inventions demonstrate his role as a leading innovator. His work not only advances scientific understanding but also has practical implications for medical and analytical applications.